Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FTNT vs MRNA✓SelectedUSD · MRNAFTNT vs MRNA performance historyLatest closeAs of-5.25%11/20
Stock and ETF performance explorer

FTNT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-4.2%
MRNA return
+323.5%
Excess return
-327.7%
Maximum drawdown
-39.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-5.2%-2.2%-3.1%-5.3%
7D-2.1%-12.7%+10.6%-2.3%
30D-28.4%-20.7%-7.8%-28.6%
3M-17.4%+46.3%-63.7%-16.7%
6M-4.2%+305.2%-309.4%+2.1%
All-4.2%+323.5%-327.7%+2.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling